Stocktoria
OPKO HEALTH, INC. OPK
OPKO HEALTH, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606.9M | $713.1M | $863.5M | $1.0B | $1.8B | $1.4B | $901.9M | $990.3M | $1.1B | $1.2B |
| Gross profit | $205.9M | $218.5M | $318.1M | $288.2M | — | — | — | — | — | — |
| R&D expense | $124.0M | $105.2M | $89.6M | $73.9M | $76.8M | $75.3M | $117.9M | $125.6M | $126.4M | $113.9M |
| SG&A expense | $223.0M | $304.2M | $300.6M | $372.7M | $468.9M | $355.6M | $343.3M | $358.3M | $414.6M | $407.3M |
| Operating income | -$117.4M | -$152.1M | -$157.0M | -$226.3M | $18.8M | $57.7M | -$274.1M | -$171.2M | -$276.4M | -$96.6M |
| Interest expense | $0 | — | $13.5M | $12.1M | $18.9M | — | — | — | — | — |
| Income tax | -$15.7M | $42.8M | $4.4M | -$63.5M | $15.5M | $17.6M | $7.1M | -$38.7M | $18.9M | -$56.1M |
| Net income | -$225.7M | -$53.2M | -$188.9M | -$328.4M | -$30.1M | $30.6M | -$314.9M | -$153.0M | -$305.2M | -$48.4M |
| EPS (diluted) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 | $0.05 | $-0.53 | $-0.27 | $-0.55 | $-0.10 |
| Operating cash flow | -$178.5M | -$183.5M | -$28.2M | -$95.2M | $38.3M | $39.5M | -$172.5M | -$109.1M | -$92.1M | $32.0M |
| Cash & equivalents | $364.4M | $426.6M | $95.9M | $153.2M | $134.7M | $72.2M | $85.5M | $96.5M | $91.5M | $168.7M |
| Inventory | $65.8M | $56.8M | $65.7M | $74.1M | $86.5M | $132.3M | $53.4M | $42.3M | $49.3M | $47.2M |
| Total assets | $1.9B | $2.2B | $2.0B | $2.2B | $2.4B | $2.5B | $2.3B | $2.5B | $2.6B | $2.8B |
| Total liabilities | $664.0M | $834.8M | $622.5M | $605.6M | $714.6M | $801.5M | $694.5M | $659.8M | $746.3M | $674.8M |
| Shareholders' equity | $1.3B | $1.4B | $1.4B | $1.6B | $1.7B | $1.7B | $1.6B | $1.8B | $1.8B | $2.0B |
Growth · year-over-year · Revenue CAGR -7.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -14.9% | -17.4% | -14.0% | -43.4% | +23.6% | +59.1% | -8.9% | -7.2% | -12.6% | +148.4% |
| Net income growth | — | — | — | — | -198.6% | — | — | — | — | — |
| EPS growth | — | — | — | — | -200.0% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.